Search
for
Sort by
Research 541–570 of 1000+
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists
- Hair Loss in a Hemodialysis Patient after Repetitive Use of the Antipruritic Drug Nalfurafine: Implications of Impaired Angiogenesis for Hair Loss
- Elucidating causal relationships of diet-derived circulating antioxidants and the risk of non-scarring alopecia: A Mendelian randomization study
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Review on Alopecia Areata in the Middle East and Africa: Landscape and Unmet Needs
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Fractional carbon dioxide laser alone and as an assisted drug delivery for treatment of alopecia areata: a clinical, dermoscopic and immunohistochemical study
- Signposts to the Promised Land in Alopecia Areata
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Alopecia Areata: An Updated Review for 2023
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Association Between Alopecia Areata and High‐Sensitivity Cardiac Troponin T as a Marker of Subclinical Myocardial Injury
- A scoping review of alopecia areata and its relationship to COVID-19 vaccinations
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Early Intervention with High-Dose Steroid Pulse Therapy Prolongs Disease-Free Interval of Severe Alopecia Areata: A Retrospective Study
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Exploring the Role of Gut Microbiota in Patients with Alopecia Areata
- Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
- Review of Superficial Cryotherapy for the Treatment of Alopecia Areata
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
- Frontiers in alopecia areata pathobiology research